Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?
Thrombosis and Haemostasis · 01.12.2023 · 123 (12) · 1177-1179
DOI: 10.1055/a-2152-4762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.12.2023. Verfasst von Stavros V Konstantinides. Beteiligte Einrichtung: Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. Hauptthemen laut MEDLINE: Venous Thromboembolism, Kidney Diseases, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
- Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece.
ORCID-Profile: Stavros V Konstantinides
Zitieren
APA
Konstantinides, S. V. (2023). Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?. Thrombosis and Haemostasis, 123(12), 1177-1179. https://doi.org/10.1055/a-2152-4762
Vancouver
Konstantinides SV. Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?. Thrombosis and Haemostasis. 2023;123(12):1177-1179. doi:10.1055/a-2152-4762
BibTeX
@article{Konstantinides2023,
author = {Konstantinides, Stavros V},
title = {Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?},
journal = {Thrombosis and Haemostasis},
year = {2023},
volume = {123},
number = {12},
pages = {1177--1179},
doi = {10.1055/a-2152-4762}
}
EUVIMED